These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3017538)

  • 1. Application of an in vitro antimetabolic assay to human germ cell testicular tumors for the preclinical evaluation of drug sensitivity.
    Sanfilippo O; Silvestrini R; Zaffaroni N; Piva L; Pizzocaro G
    Cancer; 1986 Oct; 58(7):1441-7. PubMed ID: 3017538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of an antimetabolic assay and an antiproliferative assay, both using 3H-thymidine incorporation, to test drug sensitivity of human tumors.
    Zaffaroni N; Silvestrini R; Grignolio E; Villa R; DeMarco C
    Int J Cell Cloning; 1988 Nov; 6(6):392-403. PubMed ID: 2466088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of alkylating agents on human tumors as measured by a short-term antimetabolic assay.
    Zaffaroni N; Silvestrini R; Sanfilippo O; Daidone MG; Gasparini G
    Tumori; 1985 Dec; 71(6):555-61. PubMed ID: 4082288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of in vitro drug activity to clinical response in a prospective trial for advanced germ cell testicular tumors.
    Sanfilippo O; Silvestrini R; Salvioni R; Pizzocaro G
    Eur Urol; 1989; 16(6):450-5. PubMed ID: 2556280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of an in vitro short-term assay to predict the drug sensitivity of human breast cancer.
    Daidone MG; Silvestrini R; Sanfilippo O; Zaffaroni N; Varini M; De Lena M
    Cancer; 1985 Aug; 56(3):450-6. PubMed ID: 4039971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of MDR1-expression in testicular germ cell cancer.
    Schrader AJ; Seger M; Konrad L; Olbert P; Hegele A; Hofmann R; Heidenreich A
    Exp Oncol; 2007 Sep; 29(3):212-6. PubMed ID: 18004247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigational targeted therapies for the treatment of testicular germ cell tumors.
    Oing C; Kollmannsberger C; Oechsle K; Bokemeyer C
    Expert Opin Investig Drugs; 2016 Sep; 25(9):1033-43. PubMed ID: 27286362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance.
    Mueller T; Mueller LP; Luetzkendorf J; Voigt W; Simon H; Schmoll HJ
    Tumour Biol; 2006; 27(2):71-83. PubMed ID: 16557044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum miRNA Predicts Viable Disease after Chemotherapy in Patients with Testicular Nonseminoma Germ Cell Tumor.
    Leão R; van Agthoven T; Figueiredo A; Jewett MAS; Fadaak K; Sweet J; Ahmad AE; Anson-Cartwright L; Chung P; Hansen A; Warde P; Castelo-Branco P; O'Malley M; Bedard PL; Looijenga LHJ; Hamilton RJ
    J Urol; 2018 Jul; 200(1):126-135. PubMed ID: 29474847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-reduced first cycle of chemotherapy for prevention of life-threatening acute complications in nonseminomatous germ cell tumor patients with ultra high tumor markers and/or poor performance status.
    Tryakin A; Fedyanin M; Bulanov A; Kashia S; Kurmukov I; Matveev V; Fainstein I; Gordeeva O; Zakharova T; Tjulandin S
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1817-1823. PubMed ID: 29974210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soft agarose colony formation assay for human renal cell carcinoma: comparison of optical colony counting versus tritiated thymidine incorporation.
    Hosaka Y; Tsukamoto T; Lieber MM
    J Urol; 1986 Nov; 136(5):1102-9. PubMed ID: 3773078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of vitamin D on cisplatin sensitivity in testicular germ cell cancer-derived cell lines and in a NTera2 xenograft model.
    Jørgensen A; Blomberg Jensen M; Nielsen JE; Juul A; Rajpert-De Meyts E
    J Steroid Biochem Mol Biol; 2013 Jul; 136():238-46. PubMed ID: 23098692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open-label, multicenter phase II trial of capecitabine in patients with cisplatin-refractory or relapsed germ cell tumors.
    Oechsle K; Honecker F; Kollmannsberger C; Rick O; Grünwald V; Mayer F; Hartmann JT; Bokemeyer C
    Anticancer Drugs; 2007 Mar; 18(3):273-6. PubMed ID: 17264758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCL1 protein expression in testicular germ cell tumors.
    Lau SK; Weiss LM; Chu PG
    Am J Clin Pathol; 2010 May; 133(5):762-6. PubMed ID: 20395523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapeutic sensitivity of testicular germ cell tumors under hypoxic conditions is negatively regulated by SENP1-controlled sumoylation of OCT4.
    Wu YC; Ling TY; Lu SH; Kuo HC; Ho HN; Yeh SD; Shen CN; Huang YH
    Cancer Res; 2012 Oct; 72(19):4963-73. PubMed ID: 23002208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testicular germ cell tumors. An update on clinical pathologic correlation.
    Abu-Jawdeh GM; Oyasu R
    Acta Pathol Jpn; 1991 Feb; 41(2):83-93. PubMed ID: 1645924
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular biology of testicular germ cell tumors: unique features awaiting clinical application.
    Boublikova L; Buchler T; Stary J; Abrahamova J; Trka J
    Crit Rev Oncol Hematol; 2014 Mar; 89(3):366-85. PubMed ID: 24182421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis regulation and spontaneous apoptosis index of testicular germ cell tumors are associated with differentiation and resistance to systemic treatment.
    Mandoky L; Szende B; Géczi L; Bodrogi I; Kásler M; Bak M
    Anticancer Res; 2008; 28(3A):1641-9. PubMed ID: 18630521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why doesn't high-dose chemotherapy improve survival, as was expected, in advanced or relapsed germ cell tumours?
    Pizzocaro G; Guarneri A
    Eur Urol; 2009 Jul; 56(1):46-7. PubMed ID: 19303203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.